Chapter 8. Vasculature-targeting Therapies and Hyperthermia

  1. Dietmar W. Siemann3,4
  1. Michael R. Horsman1,
  2. Rumi Murata2

Published Online: 31 MAY 2006

DOI: 10.1002/0470035439.ch8

Vascular-Targeted Therapies in Oncology

Vascular-Targeted Therapies in Oncology

How to Cite

Horsman, M. R. and Murata, R. (2006) Vasculature-targeting Therapies and Hyperthermia, in Vascular-Targeted Therapies in Oncology (ed D. W. Siemann), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470035439.ch8

Editor Information

  1. 3

    Shands Cancer Center, University of Florida, Gainsville, Florida, USA

  2. 4

    Research Department of Radiation Oncology, University of Florida, 2000 RW Archer Road, Gainsville, FL 32610, USA

Author Information

  1. 1

    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, Building 5, 8000 Aarhus C, Denmark

  2. 2

    Department of Biophysics, Institute for Cancer Research, The Norwegian Radium Hospital Montebello, 0310 Olso, Norway

Publication History

  1. Published Online: 31 MAY 2006
  2. Published Print: 10 MAR 2006

ISBN Information

Print ISBN: 9780470012949

Online ISBN: 9780470035436

SEARCH

Keywords:

  • vascular targeting agents (VTAs) and hyperthermia;
  • enhancing hyperthermia;
  • inhibiting tumor blood flow with physical clamping;
  • vasculature-targeting therapies and hyperthermia;
  • enhancing thermoradiotherapy;
  • angiogenesis inhibitors;
  • VTAs - improving tumor response;
  • maximal vascular shutdown by VDA

Summary

This chapter contains sections titled:

  • Introduction

  • Enhancing hyperthermia

  • Enhancing thermoradiotherapy

  • Conclusions and clinical relevance

  • Acknowledgments

  • References